By: J.S., STA
Drug maker Krka reported a group net profit of EUR 304.7 million for 2021, a rise of 5% year-on-year, on the back of sales revenue that rose by 2% to a record EUR 1.57 billion.
CEO Jože Colarič said that Krka saw record sales in all of its regions, except Western Europe, with profitability at a high level. For this year, Krka plans sales at EUR 1.61 billion and net profit at EUR 300 million, with EUR 130 million to go for investment.
